Atazanavir Sulfate
- Product NDC
- 51407-172
- 11-digit product format
- 514070172
- Labeler code
- 51407
- Product ID
- 51407-172_cecd8318-1a90-67f9-e053-2995a90afde4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir Sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply Inc.
- Application
- ANDA091673
- Marketing category
- ANDA
- Marketing start
- 2017-12-27
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-172-60 | 51407017260 | 60 CAPSULE in 1 BOTTLE (51407-172-60) | 60 capsule | 2017-12-27 | 0000-00-00 | No | No | Current |